INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 427
09/10/2015
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
Termini exhaurit
INNOVATIVE MEDICINES INITIATIVE
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
 
Borses de viatge
Termini exhaurit
THE EUROPEAN FOUNDATION FOR ALCOHOL RESEARCH
The European Foundation for Alcohol Research is an independent European alcohol research foundation, established in Brussels in 2003. ERAB was established to fund biomedical and psychosocial research into beer and other alcoholic drinks.
This initiative is supported by The Brewers of Europe, the voice of the brewing industry in Europe, whose members are the national brewing trade associations, representing more than 90% of European beer production.
 
Termini exhaurit
THE EUROPEAN FOUNDATION FOR ALCOHOL RESEARCH
The European Foundation for Alcohol Research is an independent European alcohol research foundation, established in Brussels in 2003. ERAB was established to fund biomedical and psychosocial research into beer and other alcoholic drinks.
This initiative is supported by The Brewers of Europe, the voice of the brewing industry in Europe, whose members are the national brewing trade associations, representing more than 90% of European beer production.
 
Termini exhaurit
DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
 
Termini exhaurit
EUROPEAN RESPIRATORY SOCIETY
ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
 
Premis
Termini exhaurit
FUNDACIÓN BENÉFICA ANTICÁNCER SAN FRANCISCO JAVIER Y SANTA CÁNDIDA DE GRANADA
Promoure la recerca oncològica general, donar suport al desenvolupament científic de l'oncologia espanyola i reconèixer la tasca realitzada pels investigadors.
 
Termini exhaurit
EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES
ESCMID has evolved to become Europe’s leading society in clinical microbiology and infectious diseases with members from all European countries and all continents. For more than 30 years, ESCMID has been an influential component in the professional lives of microbiologists and infectious disease specialists and now reaches more than 33’000 members and affiliated members around the world.
 
 
 
Informació últil
 
 No hi ha novetats
 
 
Banner-convocatories-tancament-02
Projectes
Termini exhaurit
FUNDACION SALUD 2000
Aquestes ajudes estan destinades a finançar projectes d'investigació inèdits, presentats per investigadors que puguin portar a terme l'estudi proposat a Espanya.
 
Termini exhaurit
FIPSE - FUNDACIÓN PARA LA INVESTIGACIÓN Y LA PREVENCIÓN DEL SIDA EN ESPAÑA
FIPSE ha decidit focalitzar-se en la innovació i la translació de projectes des de l'àmbit sanitari al mercat i als pacients. Amb tal propòsit, ha dissenyat un programa d'impuls a la innovació en salut el “Programa de suport a la innovació en salut” o el “Programa”, com a instrument de suport i acompanyament continuat que faciliti l'estructuració de projectes de recerca i/o assistencials, amb l'objectiu que tinguin major potencial per ser transferits i puguin convertir-se en solucions eficients i innovadores que millorin la qualitat de vida dels ciutadans i dels serveis sanitaris.
 
Termini exhaurit
CANCER RESEARCH INSTITUTE
 
Termini exhaurit
BILL & MELINDA GATES FOUNDATION
 
Termini exhaurit
BrightFocus Foundation
BrightFocus Foundation is a nonprofit organization supporting research and providing public education to help eradicate brain and eye diseases, including Alzheimer's disease, macular degeneration, and glaucoma.
 
Termini exhaurit
WORLDWIDE CANCER RESEARCH
The goal of the Worldwide Cancer Research (formerly known as AICR) is to support research that might in future help reduce the incidence of cancer or improve cancer survival. The grants support fundamental or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer. This remit is usually interpreted conservatively.
WCR does not support clinical research, including clinical trials, patient care, nursing or healthcare delivery research. It also does not support other types of applied cancer research such as policy, public health or psychosocial research.
Proposals that contain a small clinical element as an essential part of a basic or translational research project are often permitted, but you are advised to contact Grant Round Manager, Lynn Turner (lynnt@worldwidecancerresearch.org) for advice before submitting your proposal.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
AstraZeneca is a global pharmaceutical organisation commited to innovative solutions that support patients, physicians and healthcare systems to address the global burden of diabetes.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
 
Termini exhaurit
BD BIOSCIENCES
El programa d'ajuts a la recerca en immunologia té per objectiu donar suport a idees innovadores dins de les següents àrees de recerca:
  • Multicolor flow cytometry
  • Cell signaling
  • Cancer research
  • Immune function
  • Infectious diseases
  • Neuroscience research
    		•
     
    Borses de viatge
    Termini exhaurit
    EUROPEAN SOCIETY OF SURGICAL ONCOLOGY
    ESSO’s mission is to support its members in advancing the science and practice of surgical oncology for the benefit of cancer patients through a range of activities including education, research and leadership in multidisciplinary care.
    The aim of the Training Fellowships is to allow young surgeons to visit a specialist centre outside of their own country,and help them expand their experience and learn new techniques.
     
    Termini exhaurit
    UNIVERSIDAD DE BARCELONA
    Fundada pel doctor Agustí Pedro i Pons l'any 1971, és una entitat beneficodocent, la finalitat de la qual és l'atorgament d'ajuts per a estudis de postgrau a favor de llicenciats procedents de la Universitat de Barcelona, de les facultats de Biologia, Farmàcia, Filologia, Filosofia, Física, Geologia, Geografia i Història, Matemàtiques, Medicina, Pedagogia, Psicologia i Química.
     
    Termini exhaurit
    SOCIEDAD ESPAÑOLA DE ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA
    Ajudar a finançar l'intercanvi de coneixements i experiències entre grups de treball a Espanya i a l'estranger en els àmbits de la Microbiologia Clínica i de les Malalties Infeccioses. (1 a 3 setmanes)
     
    Termini exhaurit
    SOCIEDAD ESPAÑOLA DE ENFERMEDADES INFECCIOSAS Y MICROBIOLOGÍA CLÍNICA
    Ajudar a finançar l´intercanvi de coneixements i experiències ente grups de treball a Espanya i a l´estranger en els àmbits de la Microbiologia Clínica i de les Malalties Infeccioses. (1 a 3 mesos)
     
    Premis
    Termini exhaurit
    FUNDACIÓN LILLY
    La "Fundación Lilly" i la "Universidad Complutense de Madrid" han signat un conveni per a la creació d'aquesta càtedra que té per objectiu adquirir, transmetre i aplicar els avenços i coneixements per a la millora de l'ensenyament de la medicina i la formació del metge.
     
    Termini exhaurit
    The Warren Alpert Foundation
    The Warren Alpert Foundation Prize, in association with Harvard Medical School, recognizes and honors one or more scientists, physicians and researchers whose scientific achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease.
     
    Termini exhaurit
    FCT - FUNDACIÓ CATALANA DE TRASPLANTAMENT
    Premiar el millor article sobre trasplantament d’òrgans sòlids, segons criteri del Jurat, publicat en qualsevol revista científica espanyola o estrangera, en el període comprès entre l'1 d’octubre de 2014 i el 30 setembre del 2015. El referit article caldrà que s’hagi efectuat en un grup d’ investigació radicat a Catalunya o a la resta de l’Estat Espanyol de forma exclusiva o en cooperació. Si l'article premiat ha estat redactat per una pluralitat de persones, el premi s' atorgarà al primer sotasignant de l'article.
     
    Termini exhaurit
    REIAL ACADÈMIA DE FARMÀCIA DE CATALUNYA
    Es crea el Premi "Federació Farmacèutica", de la Reial Acadèmia de Farmàcia de Catalunya (RAFC) per premiar aquelles persones individuals, grups o entitats que s'hagin distingit en el servei de la Farmàcia en general i/o en el camp de la distribució farmacèutica en particular, en l'àmbit de Catalunya o a la resta de l'Estat Espanyol.
     
    Termini exhaurit
    EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES
    ESCMID has evolved to become Europe’s leading society in clinical microbiology and infectious diseases with members from all European countries and all continents. For more than 30 years, ESCMID has been an influential component in the professional lives of microbiologists and infectious disease specialists and now reaches more than 33’000 members and affiliated members around the world.
     
    Termini exhaurit
    FUNDACIÓ SANTIAGO DEXEUS
    PREMI concedit a la persona, persones, equip de treball o institució amb una trajectòria professional o línia de recerca continuada la qual representi una contribució rellevant en el camp de les Ciències de la Salut, especialment referides a la dona i particularment en l'àmbit de l'Obstetrícia, la Ginecologia i la Medicina de la Reproducció. Àmbit Internacional.
     
    Recursos Humans
    Termini exhaurit
    AXA RESEARCH FUND
    To fund basic research dedicated to a better understanding of risk. The word risk as we understand it is connected to: Phenomena that are perceived -or yet to be perceived-as hazards or threats and wich must be identified and mesured for frequency and impact.
     
    Termini exhaurit
    FCT - FUNDACIÓ CATALANA DE TRASPLANTAMENT
    La present convocatòria es realitza amb l’objecte de fomentar la recerca científica en el trasplantament d’òrgan sòlid, a investigadors que formin part de les àrees de recerca que estan en funcionament en els serveis amb Unitat de Trasplantament de Catalunya.
    La finalitat primordial de la present beca serà la de facilitar l’estudi i la formació del becari, sense que comporti cap aportació al centre u organisme ni la incorporació dels resultats aconseguits al patrimoni de la organització.
     
    Termini exhaurit
    FUNDACIÓ SANTIAGO DEXEUS
    Convocatòria nacional de cinc beques d'investigació en els camps de:
  • Ginecologia general
  • Medicina materno fetal
  • Ginecologia oncològica
  • Medicina de la reproducció
  • Investigació bàsica en l'àmbit de l'obstetrícia i la ginecologia.
    		•
     
    Termini exhaurit
    CENTRO DE INFORMACIÓN CERVEZA Y SALUD
    Concedir dues beques per a la realització de treballs de recerca experimental sobre el consum moderat de cervesa en relació amb la salut i la nutrició, que no s’hagin difós amb anterioritat a Espanya.
     
    Termini exhaurit
    INTERNATIONAL UNION AGAINST CANCER
    The ACSBI fellowship emphasizes the transfer of knowledge from a host institute to the applicant and others at the fellow's home institute. The goals include not only developing future leaders in cancer research with an orientation to research in low- and middle-income countries, but also facilitating a global effort in cancer prevention and control.
     
     
     
     
    Articles
     
    Corominas H*, Narvaez J, Díaz-Torner C, Salvador G, Gómez-Caballero ME, de la Fuente D, Campoy E, Roig-Vilaseca D, Clavaguera T, Morlà R, Torrente V, Arasa X, Gómez-Puerta JA, Möller I, Alegre C, Graell E, Ponce A, Lisbona-Pérez MP, Pérez-García C, Fíguls R, Sirvent E, Poca V, Sanmarti R. Retraso diagnóstico y terapéutico de la artritis reumatoide y su relación con dispositivos asistenciales en Catalunya. Estudio AUDIT. Reumatol Clin 2016; 12(3): 146-150.
     
    Cano M, Cardoner N*, Urretavizcaya M, Martínez-Zalacaín I, Goldberg X, Via E, Contreras-Rodríguez O, Camprodon JA, de Arriba-Arnau A, Hernández-Ribas R, Pujol J, Soriano-Mas C*, Menchón JM. Modulation of Limbic and Prefrontal Connectivity by Electroconvulsive Therapy in Treatment-resistant Depression: A Preliminary Study. Brain Stimul 2016; 9(1): 65-71.
     
    Chacón-Cabrera A, Fermoselle C, Salmela I, Yelamos J, Barreiro E*. MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1-/- and Parp-2-/- mice with lung cancer cachexia. BBA-Gen Subjects 2015; 1850(12): 2530-2543.
     
    Pippias M*, Jager KJ, Kramer A, Leivestad T, Benítez-Sánchez M, Caskey F, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2016; 31(5): 831-841.
     
    Diaz-Beya M, Brunet S, Nomdedeu J, Cordeiro A, Tormo M, Escoda L, Ribera JM, Arnan M, Heras I, Gallardo D, Bargay J, Queipo de Llano MP, Salamero O, Martí JM, Sampol A, Pedro C, Hoyos M, Pratcorona M, Catellano J, Nomdedeu M, Risueño RM, Sierra J, Monzó M, Navarro A, Esteve J*. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia. Blood Cancer J 2015; 5: e352.
     
    Decara JM, Pavón FJ, Suárez J, Romero M, Baixeras E, Vazquez M, Rivera P, Gavito AL, Almeida B, Joglar J, de la Torre R, Rodriguez-de Fonseca F*, Serrano A*. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats. Dis Model Mech 2015; 8(10): 1213-1225.
     
    Cañadas I*, Taus A, Villanueva X, Arpí O, Pijuan L, Rodriguez Y, Menéndez S, Mojal S, Rojo F, Albanell J, Rovira A, Arriola E. Angiopoietin-2 is a negative prognostic marker in small cell lung cancer. Lung Cancer 2015; 90(2): 302-306.
     
    Vidal D*, Salleras M, Romaní J, Ribera M, Gallardo F, Viñas M, Xifra A, García-Navarro X, Bordas X, Ferran M, Carrascosa JM. Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasis. J Eur Acad Dermatol Venereol 2016; 30(11): e131-e132.
     
    Subirana J*, Albà MM, Messeguer X. High evolutionary turnover of satellite families in Caenorhabditis. BMC Evol Biol 2015; 15(1): 218.
     
    Gutiérrez F*, Aluja A, Peri JM, Calvo N, Ferrer M, Baillés E, Gutiérrez-Zotes A, Garriz M, Caseras X, Markon KE, Krueger RF. Psychometric Properties of the Spanish PID-5 in a Clinical and a Community Sample. Assessment 2017; 24(3): 326-336.
     
    Rava M*, Le Moual N, Dumont X, Guerra S, Siroux V, Jacquemin B, Kauffmann F, Bernard A, Nadif R. Serum club cell protein 16 is associated with asymptomatic airway responsiveness in adults: Findings from the French epidemiological study on the genetics and environment of asthma. Respirology 2015; 20(8): 1198-1205.
     
    Scarisbrick JJ*, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martínez-Escala E, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero P.L, Rodríguez Peralto J.L, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol 2015; 33(32): 3766-3773.
     
    Vallecillo G*, Mojal S, Roquer A, Samos P, Luque S, Martínez-Sanvisens D, Martires PK, Torrens M*. Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center. AIDS Behav 2016; 20(5): 1068-1075.
     
    Marti M, Barberà MJ, Manzardo C, Ocaña I, Knobel H, Gurgui M, Humet V, Vall M, Ribera E, Villar-García J, Martín G, Sambeat MA, Marco A, Vives A, Alsina M, Miro JM, Caylà JA, and the HIV Surveillance Group. Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study. Bmc Public Health 2015; 15(1): 1015.
     
    Lorenz K*, Bartsch DK, Sancho JJ, Guigard S, Triponez F. Surgical management of secondary hyperparathyroidism in chronic kidney disease-a consensus report of the European Society of Endocrine Surgeons. Langenbecks Arch Surg 2015; 400(8): 907-927.
     
    Olazarán J, Hoyos-Alonso MC, del Ser T, Garrido-Barral A, Conde-Sala JL, Bermejo-Pareja F, López-Pousa S, Pérez-Martínez D, Villarejo-Galende A, Cacho J, Navarro E, Oliveros-Cid A, Peña-Casanova J, Carnero-Pardo C*. Aplicación práctica de los test cognitivos breves. Neurología (Barc) 2016; 31(3): 183-194.
     
     
    Ortonobes S, López-García B, Solano MF, Ferrández O*. Toxicidad hematológica durante el tratamiento con albendazol. Enferm Infecc Microbiol Clin 2016; 34(5): 326-327.
     
    Piñol S, Sala A, Guzman C, Marcos S, Joya J, Puig C, Velasco M, Velez D, Vall O, García-Algar O*. Arsenic levels in immigrant children from countries at risk of consuming arsenic polluted water compared to children from Barcelona. Environ Monit Assess 2015; 187(11): 661.
     
    Vaquerizo B*, Miranda F, Fernández E, Rumoroso JR, Gómez-Hospital JA, Bossa F, Iñiguez A, Oategui I, Serra A. Treatment of Small Vessel Disease With the Paclitaxel Drug-Eluting Balloon: 6-Month Angiographic and 1-Year Clinical Outcomes of the Spanish Multicenter Registry. J Interv Cardiol 2015; 28(5): 430-438.
     
    Jacob J*, Miró Ò, Herrero P, Martin-Sanchez FJ, Gil V, Tost J, Aguirre A, Escoda R, Alquézar A, Andueza JA, Llorens P, en representación del grupo ICA-SEMES. Predicción de la mortalidad a muy corto plazo de los pacientes con insuficiencia cardiaca crónica agudizada: escala EAHFE-3D. Medicina Intensiva 2016; 40(6): 348-355.
     
    Masclans JR*, Pérez-Terán P, Roca O. Papel de la oxigenoterapia de alto flujo en la insuficiencia respiratoria aguda. Medicina Intensiva 2015; 39(8): 505-515.
     
    Fernández-Miró M, Chillarón JJ*, Pedro-Botet J. Déficit de testosterona, síndrome metabólico y diabetes mellitus. Med Clin (Barc) 2016; 146(2): 69-73.
     
     
    González-Macías J, del Pino J, Olmos JM, Nogués X*, en nombre de la Comisión de Redacción de las Guías de Osteoporosis de la SEIOMM. Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral (3.ª versión actualizada 2014). Rev Clin Esp 2015; 215(9): 515-526.
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).